Janice C. Parker

839 total citations
23 papers, 689 citations indexed

About

Janice C. Parker is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Janice C. Parker has authored 23 papers receiving a total of 689 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 12 papers in Endocrinology, Diabetes and Metabolism and 7 papers in Surgery. Recurrent topics in Janice C. Parker's work include Diabetes Treatment and Management (10 papers), Pancreatic function and diabetes (7 papers) and Peptidase Inhibition and Analysis (6 papers). Janice C. Parker is often cited by papers focused on Diabetes Treatment and Management (10 papers), Pancreatic function and diabetes (7 papers) and Peptidase Inhibition and Analysis (6 papers). Janice C. Parker collaborates with scholars based in United States, Australia and Japan. Janice C. Parker's co-authors include Kim Andrews, Greg J. Barritt, Melanie Allen, John D. McNeish, Jeffrey L. Stock, Leonard Jarett, Frederick L. Kiechle, Nancy A. Nardone, Maria A. VanVolkenburg and Diane M. Hargrove and has published in prestigious journals such as The Journal of Physiology, Advanced Drug Delivery Reviews and Diabetes.

In The Last Decade

Janice C. Parker

23 papers receiving 659 citations

Peers

Countries citing papers authored by Janice C. Parker

Since Specialization

Citations

This map shows the geographic impact of Janice C. Parker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Janice C. Parker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Janice C. Parker more than expected).

Fields of papers citing papers by Janice C. Parker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Janice C. Parker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Janice C. Parker. The network helps show where Janice C. Parker may publish in the future.

Co-authorship network of co-authors of Janice C. Parker

This figure shows the co-authorship network connecting the top 25 collaborators of Janice C. Parker. A scholar is included among the top collaborators of Janice C. Parker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Janice C. Parker. Janice C. Parker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Discovery of triazolopyrimidine-based PDE8B inhibitors: Exceptionally ligand-efficient and lipophilic ligand-efficient compounds for the treatment of diabetes 2012 ·Bioorganic & Medicinal Chemistry Letters ·Michael P. DeNinno, Stephen W. Wright, John B. Etienne, (unknown), Benjamin N. Rocke, Jeffrey W. Corbett, Daniel W. Kung, Kenneth J. DiRico, Kim Andrews, (unknown), Janice C. Parker, William P. Esler, (unknown), (unknown), Karen L. Houseknecht, Shawn D. Doran	22
2	1-((3S,4S)-4-Amino-1-(4-substituted-1,3,5-triazin-2-yl) pyrrolidin-3-yl)-5,5-difluoropiperidin-2-one inhibitors of DPP-4 for the treatment of type 2 diabetes 2011 ·Bioorganic & Medicinal Chemistry Letters ·Kim Andrews, David A. Beebe, John W. Benbow, (unknown), Shawn D. Doran, Hui Yu, Shenping Liu, R. Kirk McPherson, Constantin Neagu, Janice C. Parker, David W. Piotrowski, (unknown), Judith L. Treadway, (unknown), William J. Zembrowski	16
3	(3,3-Difluoro-pyrrolidin-1-yl)-[(2S,4S)-(4-(4-pyrimidin-2-yl-piperazin-1-yl)-pyrrolidin-2-yl]-methanone: A potent, selective, orally active dipeptidyl peptidase IV inhibitor 2009 ·Bioorganic & Medicinal Chemistry Letters ·Mark Ammirati, Kim Andrews, (unknown), (unknown), Dennis E. Danley, Shawn D. Doran, Bernard Hulin, Shenping Liu, R. Kirk McPherson, Stephen Orena, Janice C. Parker, Jana Polívková, Xiayang Qiu, (unknown), Judith L. Treadway, Maria A. VanVolkenburg, (unknown), David W. Piotrowski	33
4	Piperidinyl-2-phenethylamino inhibitors of DPP-IV for the treatment of Type 2 diabetes 2009 ·Bioorganic & Medicinal Chemistry Letters ·John W. Benbow, (unknown), Jiri Aubrecht, David A. Beebe, (unknown), Shawn D. Doran, (unknown), Hui Yu, (unknown), Janice C. Parker, Judith L. Treadway, (unknown), William J. Zembrowski	6
5	(3R,4S)-4-(2,4,5-Trifluorophenyl)-pyrrolidin-3-ylamine inhibitors of dipeptidyl peptidase IV: Synthesis, in vitro, in vivo, and X-ray crystallographic characterization 2007 ·Bioorganic & Medicinal Chemistry Letters ·Stephen W. Wright, Mark Ammirati, Kim Andrews, (unknown), Dennis E. Danley, Shawn D. Doran, Jay S. Lillquist, Shenping Liu, Lester D. McClure, R. Kirk McPherson, (unknown), Stephen Orena, Janice C. Parker, Benjamin N. Rocke, Walter C. Soeller, (unknown), Judith L. Treadway, Maria A. VanVolkenburg, (unknown), Eric Cox	13
6	cis-2,5-Dicyanopyrrolidine Inhibitors of Dipeptidyl Peptidase IV: Synthesis and in Vitro, in Vivo, and X-ray Crystallographic Characterization 2006 ·Journal of Medicinal Chemistry ·Stephen W. Wright, Mark Ammirati, Kim Andrews, (unknown), Dennis E. Danley, Shawn D. Doran, Jay S. Lillquist, Lester D. McClure, R. Kirk McPherson, Stephen Orena, Janice C. Parker, Jana Polívková, Xiayang Qiu, Walter C. Soeller, (unknown), Judith L. Treadway, Maria A. VanVolkenburg, Hong Wang, (unknown), (unknown)	28
7	New fluorinated pyrrolidine and azetidine amides as dipeptidyl peptidase IV inhibitors 2005 ·Bioorganic & Medicinal Chemistry Letters ·Bernard Hulin, Shawn Cabral, (unknown), (unknown), Kim Andrews, Janice C. Parker	26
8	Synergistic effect on insulin secretion from INS-1 cells of a sulfonylurea and a phosphodiesterase 3 inhibitor 2004 ·Life Sciences ·Janice C. Parker, Maria A. VanVolkenburg, Feng Gao	3
9	Glycemic Control in Mice with Targeted Disruption of the Glucagon Receptor Gene 2002 ·Biochemical and Biophysical Research Communications ·Janice C. Parker, Kim Andrews, Melanie Allen, Jeffrey L. Stock, John D. McNeish	124
10	CJ-21,164, a New D-Glucose-6-phosphate Phosphohydrolase Inhibitor Produced by a Fungus Chloridium sp. 2002 ·The Journal of Antibiotics ·Yoon-Jeong Kim, Hiroyuki Nishida, (unknown), Toshiyuki Saito, Shinichi Sakemi, Hiroko Tonai‐Kachi, Nobuji Yoshikawa, Maria A. VanVolkenburg, Janice C. Parker, Yasuhiro Kojima	9
11	Thielavins as Glucose-6-phosphatase (G6Pase) Inhibitors: Producing Strain, Fermentation, Isolation, Structural Elucidation and Biological Activities. 2002 ·The Journal of Antibiotics ·Shinichi Sakemi, Hideo Hirai, Toshio Ichiba, TAISUKE INAGAKI, (unknown), Nakao Kojima, Hiroyuki Nishida, Janice C. Parker, Toshiyuki Saito, Hiroko Tonai‐Kachi, Maria A. VanVolkenburg, Nobuji Yoshikawa, Yasuhiro Kojima	28
12	Modulation of Insulin Secretion and Glycemia by Selective Inhibition of Cyclic AMP Phosphodiesterase III 1997 ·Biochemical and Biophysical Research Communications ·Janice C. Parker, Maria A. VanVolkenburg, Nancy A. Nardone, Diane M. Hargrove, Kim Andrews	25
13	VSEPR theory demo 1997 ·Journal of Chemical Education ·Janice C. Parker	1
14	Comparison of the glucose dependency of glucagon-like peptide-1(7–37) and glyburide in vitro and in vivo 1996 ·Metabolism ·Diane M. Hargrove, Nancy A. Nardone, (unknown), Kim Andrews, (unknown), Ralph W. Stevenson, Janice C. Parker	14
15	Glucose-dependent action of glucagon-like peptide-1(7-37) in vivo during short- or long-term administration 1995 ·Metabolism ·Diane M. Hargrove, Nancy A. Nardone, (unknown), Janice C. Parker, Ralph W. Stevenson	30
16	Analysis of the glucose transporter content of islet cell lines: Implications for glucose-stimulated insulin release 1992 ·Cellular Signalling ·(unknown), Scott C. McCoid, Helen Thomas, Stephen A. Baldwin, Anthony Davies, Janice C. Parker, E. Michael Gibbs, Gwyn W. Gould	33
17	Control of Glucose Metabolism in Pancreatic β-Cells by Glucokinase, Hexokinase and Phosphofructokinase: Model Study With Cell Lines Derived From β-Cells 1988 ·Diabetes ·Takao Shimizu, Janice C. Parker, Habiba Najafi, Franz M. Matschinsky	36
18	Some properties of the nadp+dependent isocitrate dehydrogenase of rat and pig ovary 1983 ·International Journal of Biochemistry ·Patricia M. Stevenson, Janice C. Parker, (unknown), (unknown), Deborah J. Norman, (unknown), (unknown), Geraldine Lee	5
19	Partial purification from hepatoma cells of an intracellular substance which mediates the effects of insulin on pyruvate dehydrogenase and low Km cyclic AMP phosphodiesterase 1982 ·Archives of Biochemistry and Biophysics ·Janice C. Parker, Frederick L. Kiechle, Leonard Jarett	37
20	A kinetic analysis of the effects of adrenaline on calcium distribution in isolated rat liver parenchymal cells 1981 ·The Journal of Physiology ·Greg J. Barritt, Janice C. Parker, (unknown)	120

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact